Clinical Benefit with PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report
Frontiers in oncology（2022）
关键词
PARP inhibitor,ovarian cancer,germline,FANCA,clinical benefit
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要